This week in drug discovery (4-8 April) 

News round-up by DDW’s Megan Thomas for 4-8 April  

When considering trends in the drug discovery industry, the use of technology to advance treatments and therapeutics is consistently observed. DDW rounds up five of this week’s top news stories which reveal this theme of technology, AI and biotechnology.  

1. Jumpcode Genomics launches tech to improve genome sequencing 

Genome technology platform provider Jumpcode Genomics has launched technology to improve single cell transcriptional profiling and aid with scientists’ understanding of genomic sequences.   

2. Iktos teams up with Ono Pharmaceuticals on AI project 

Artificial intelligence (AI) company Iktos has announced a collaboration with Ono Pharmaceuticals focused on expediting drug discovery for pre-clinical candidates.   

3. Evonetix granted patent for DNA synthesis tech 

Synthetic biology company Evonetix’ has been granted a patent in Europe for its proprietary thermal control technology for DNA synthesis, as well as the design and manufacture of its silicon chips. 

4. eTheRNA expands R&D capacity 

mRNA technology discovery and development company, eTheRNA immunotherapies has announced it has relocated its R&D group to a larger site in Belgium.   

5. Cell Guidance Systems & Manchester Biogel launch adaptable 3D cell culture 

Cell Guidance Systems, a specialist in the control, manipulation, and monitoring of cells and biotech company Manchester Biogel have launched an adaptable environment for 3D cell culture.       

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free